Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 77

The DOI matches its Crossref record.

Gram-negative endolysins: overcoming the outer membrane obstacle

Sisson, Hazel M, Jackson, Simon A, Fagerlund, Robert D, Warring, Suzanne L, Fineran, Peter C · 2024 · Current Opinion in Microbiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mib.2024.102433

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 66

  1. Gutiérrez, 2021, Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go, Curr Opin Biotechnol, 68, 15, 10.1016/j.copbio.2020.08.014 · doi:10.1016/j.copbio.2020.08.014
  2. Love, 2020, On the catalytic mechanism of bacteriophage endolysins: opportunities for engineering, Biochim Biophys Acta (BBA) — Proteins Proteom, 1868, 10.1016/j.bbapap.2019.140302 · DOI
  3. Fischetti, 2010, Bacteriophage endolysins: a novel anti-infective to control gram-positive pathogens, Int J Med Microbiol, 300, 357, 10.1016/j.ijmm.2010.04.002 · DOI · Paper page
  4. Chu, 2022, Novel phage lysin Abp013 against Acinetobacter baumannii,, Antibiotics, 11, 196, 10.3390/antibiotics11020169 · DOI
  5. Larpin, 2018, In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria, PLoS One, 13, 10.1371/journal.pone.0192507 · DOI
  6. Deng, 2023, The broad-spectrum endolysin LySP2 improves chick survival after Salmonella Pullorum infection, Viruses, 15, 836, 10.3390/v15040836 · doi:10.3390/v15040836
  7. Euler, 2023, PlyKp104, a novel phage lysin for the treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and other Gram-Negative ESKAPE pathogens, Antimicrob Agents Chemother, 67, 10.1128/aac.01519-22 · DOI
  8. Vázquez, 2022, Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain, Acta Crystallogr Sect D, 78, 435, 10.1107/S2059798322000936 · doi:10.1107/s2059798322000936
  9. Thandar, 2016, Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii, Antimicrob Agents Chemother, 60, 2671, 10.1128/AAC.02972-15 · DOI
  10. Abdelkader, 2020, Lysin LysMK34 of Acinetobacter baumannii bacteriophage PMK34 has a turgor pressure-dependent intrinsic antibacterial activity and reverts colistin resistance, Appl Environ Microbiol, 86, 19, 10.1128/AEM.01311-20 · DOI
  11. Wang, 2020, TSPphg lysin from the extremophilic thermus bacteriophage TSP4 as a potential antimicrobial agent against both Gram-Negative and Gram-Positive pathogenic bacteria, Viruses, 12, 192, 10.3390/v12020192 · DOI
  12. Plotka, 2019, Ts2631 endolysin from the extremophilic Thermus scotoductus bacteriophage vB_Tsc2631 as an antimicrobial agent against gram-negative multidrug-resistant bacteria, Viruses, 11, 10.3390/v11070657 · DOI
  13. Abdelrahman, 2023, Pseudomonas phage ZCPS1 endolysin as a potential therapeutic agent, Viruses, 15, 520, 10.3390/v15020520 · DOI
  14. Premetis, 2023, Metaviromics analysis of marine biofilm reveals a glycoside hydrolase endolysin with high specificity towards Acinetobacter baumannii, Biochim Biophys Acta Proteins Proteom, 1871, 10.1016/j.bbapap.2023.140918 · DOI
  15. Premetis, 2023, Characterization of a glycoside hydrolase endolysin from Acinetobacter baumannii phage AbTZA1 with high antibacterial potency and novel structural features, Febs J, 290, 2146, 10.1111/febs.16686 · DOI
  16. Wang, 2020, MMPphg from the thermophilic Meiothermus bacteriophage MMP17 as a potential antimicrobial agent against both Gram-negative and Gram-positive bacteria, Virol J, 17, 10.1186/s12985-020-01403-0 · doi:10.1186/s12985-020-01403-0
  17. Peng, 2017, Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2, Sci Rep, 7, 1, 10.1038/s41598-017-11832-7 · DOI
  18. Raz, 2019, Isolation of phage lysins that effectively kill Pseudomonas aeruginosa in mouse models of lung and skin infection, Antimicrob Agents Chemother, 63, 10.1128/AAC.00024-19 · DOI
  19. Vázquez, 2022, Improvement of the antibacterial activity of phage lysin-derived peptide P87 through maximization of physicochemical properties and assessment of its therapeutic potential, Antibiotics, 11, 10.3390/antibiotics11101448 · doi:10.3390/antibiotics11101448
  20. Gontijo, 2021, Current status of endolysin-based treatments against Gram-Negative bacteria, Antibiotics, 10, 10.3390/antibiotics10101143 · DOI
  21. Oliveira, 2016, Structural and enzymatic characterization of ABgp46, a novel phage endolysin with broad anti-gram-negative bacterial activity, Frontiers in Microbiology, 7, 10.3389/fmicb.2016.00208 · DOI
  22. Ni, 2021, Characterization of a lytic bacteriophage against Pseudomonas syringae pv. actinidiae and its endolysin, Viruses, 13, 10.3390/v13040631 · doi:10.3390/v13040631
  23. Walmagh, 2013, Characterization of five novel endolysins from Gram-negative infecting bacteriophages, Appl Microbiol Biotechnol, 97, 4369, 10.1007/s00253-012-4294-7 · DOI
  24. Nie, 2022, An endolysin Salmcide-p1 from bacteriophage fmb-p1 against gram-negative bacteria, J Appl Microbiol, 133, 1597, 10.1111/jam.15661 · DOI
  25. Briers, 2011, Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa, J Appl Microbiol, 110, 778, 10.1111/j.1365-2672.2010.04931.x · DOI · Paper page
  26. Banfi, 2007, The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes, Clin Chem Lab Med, 45, 565, 10.1515/CCLM.2007.110 · DOI · Paper page
  27. Egli, 2001, Biodegradation of metal-complexing aminopolycarboxylic acids, J Biosci Bioeng, 92, 89, 10.1016/S1389-1723(01)80207-3 · doi:10.1016/s1389-1723(01)80207-3
  28. Sisson, 2024, Antibacterial synergy between a phage endolysin and citric acid against the Gram-negative kiwifruit pathogen Pseudomonas syringae pv. actinidiae, Appl Environ Microbiol, 90
  29. Zermeño-Cervantes, 2023, Evaluating the efficacy of endolysins and membrane permeabilizers against Vibrio parahaemolyticus in marine conditions, Res Microbiol, 174, 10.1016/j.resmic.2023.104104 · doi:10.1016/j.resmic.2023.104104
  30. Blasco, 2020, In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens, Sci Rep, 10, 10.1038/s41598-020-64145-7 · DOI
  31. Hong, 2022, Combination effect of engineered endolysin EC340 with antibiotics, Front Microbiol, 13, 10.3389/fmicb.2022.821936 · DOI
  32. Baliga, 2023, Cloning, characterization, and antibacterial properties of endolysin LysE against planktonic cells and biofilms of Aeromonas hydrophila, Probiotics Antimicrob Proteins, 15, 646, 10.1007/s12602-021-09880-7 · doi:10.1007/s12602-021-09880-7
  33. Kim, 2023, Combined antimicrobial effect of phage-derived endolysin and depolymerase against biofilm-forming Salmonella Typhimurium, Biofouling, 39, 763, 10.1080/08927014.2023.2265817 · doi:10.1080/08927014.2023.2265817
  34. Shen, 2023, Characterization of a broad-spectrum endolysin rLysJNwz and its utility against Salmonella in foods, Appl Microbiol Biotechnol, 107, 3229, 10.1007/s00253-023-12500-9 · doi:10.1007/s00253-023-12500-9
  35. Ning, 2021, Synergistic effects of endolysin Lysqdvp001 and ε-poly-lysine in controlling Vibrio parahaemolyticus and its biofilms, Int J Food Microbiol, 343, 10.1016/j.ijfoodmicro.2021.109112 · doi:10.1016/j.ijfoodmicro.2021.109112
  36. Briers, 2014, Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa, Antimicrob Agents Chemother, 58, 3774, 10.1128/AAC.02668-14 · DOI · Paper page
  37. Schirmeier, 2018, Inhibitory and bactericidal effect of Artilysin® Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates, Int J Antimicrob Agents, 51, 528, 10.1016/j.ijantimicag.2017.08.027 · DOI
  38. Defraine, 2016, Efficacy of artilysin art-175 against resistant and persistent Acinetobacter baumannii, Antimicrob Agents Chemother, 60, 3480, 10.1128/AAC.00285-16 · DOI
  39. Wang, 2021, Design SMAP29-LysPA26 as a highly efficient artilysin against Pseudomonas aeruginosa with bactericidal and antibiofilm activity, Microbiol Spectr, 9, 10.1128/Spectrum.00546-21 · DOI · Paper page
  40. Jeong, 2023, Characterization of three different endolysins effective against Gram-Negative bacteria, Viruses, 15, 679, 10.3390/v15030679 · doi:10.3390/v15030679
  41. Islam, 2022, Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii, Front Microbiol, 13, 10.3389/fmicb.2022.988522 · doi:10.3389/fmicb.2022.988522
  42. Lim, 2022, Bactericidal effect of cecropin A fused endolysin on drug-resistant Gram-Negative pathogens, J Microbiol Biotechnol, 32, 816, 10.4014/jmb.2205.05009 · DOI
  43. Gerstmans, 2020, A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins, Sci Adv, 6, 10.1126/sciadv.aaz1136 · DOI
  44. Gerstmans, 2023, Distinct mode of action of a highly stable, engineered phage lysin killing Gram-negative bacteria, Microbiol Spectr, 6
  45. Chen, 2021, Membrane-permeable antibacterial enzyme against multidrug-resistant Acinetobacter baumannii, ACS Infect Dis, 7, 2192, 10.1021/acsinfecdis.1c00222 · doi:10.1021/acsinfecdis.1c00222
  46. Abdelkader, 2022, Engineering a lysin with Intrinsic Antibacterial Activity (LysMK34) by cecropin A fusion enhances its antibacterial properties against Acinetobacter baumannii, Appl Environ Microbiol, 88, e01515, 10.1128/AEM.01515-21 · doi:10.1128/aem.01515-21
  47. Wang, 2023, Crystal structure of the engineered endolysin mtEC340M, Acta Crystallogr Sect F Struct Biol Commun, 79, 105, 10.1107/S2053230X23002583 · doi:10.1107/s2053230x23002583
  48. Ning, 2021, Development of cationic peptide chimeric lysins based on phage lysin Lysqdvp001 and their antibacterial effects against Vibrio parahaemolyticus: a preliminary study, Int J Food Microbiol, 358, 10.1016/j.ijfoodmicro.2021.109396 · doi:10.1016/j.ijfoodmicro.2021.109396
  49. Wang, 2022, A single catalytic endolysin domain Plychap001: characterization and application to control Vibrio parahaemolyticus and its biofilm directly, Foods, 11, 1578, 10.3390/foods11111578 · doi:10.3390/foods11111578
  50. Nie, 2021, In Silico development of novel chimeric lysins with highly specific inhibition against Salmonella by computer-aided design, J Agric Food Chem, 69, 3751, 10.1021/acs.jafc.0c07450 · doi:10.1021/acs.jafc.0c07450
  51. Lim, 2022, Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin, J Microbiol, 60, 859, 10.1007/s12275-022-2107-y · doi:10.1007/s12275-022-2107-y
  52. Sitthisak, 2023, Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii, Sci Rep, 13, 10.1038/s41598-023-33822-8 · DOI
  53. Sui, 2023, Design, screening, and characterization of engineered phage endolysins with extracellular antibacterial activity against Gram-Negative Bacteria, Appl Environ Microbiol, 89, e00581, 10.1128/aem.00581-23 · doi:10.1128/aem.00581-23
  54. Ning, 2023, Development of highly efficient artilysins against Vibrio parahaemolyticus via virtual screening assisted by molecular docking, Food Control, 146, 10.1016/j.foodcont.2022.109521 · doi:10.1016/j.foodcont.2022.109521
  55. Heselpoth, 2019, Lysocins: Bioengineered antimicrobials that deliver lysins across the outer membrane of Gram-negative bacteria, Antimicrob Agents Chemother, 63, 10.1128/AAC.00342-19 · DOI
  56. Lukacik, 2012, Structural engineering of a phage lysin that targets Gram-negative pathogens, Proc Natl Acad Sci, 109, 9857, 10.1073/pnas.1203472109 · DOI
  57. Yan, 2017, The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly, Int J Gen Mol Microbiol, 110, 1627
  58. Nobrega, 2018, Targeting mechanisms of tailed bacteriophages, Nat Rev Microbiol, 16, 760, 10.1038/s41579-018-0070-8 · DOI · Paper page
  59. Zampara, 2020, Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria, Sci Rep, 10, 10.1038/s41598-020-68983-3 · DOI
  60. Zampara, 2021, Developing innolysins against Campylobacter jejuni using a novel prophage receptor-binding protein, Frontiers in Microbiology, 12, 10.3389/fmicb.2021.619028 · doi:10.3389/fmicb.2021.619028
  61. Athina, 2023, Martine Camilla Holst S: Campycins are novel broad spectrum antibacterials killing Campylobacter jejuni by targeting the essential major outer membrane protein (MOMP), bioRxiv
  62. Warring, 2022, A lipopolysaccharide-dependent phage infects a pseudomonad phytopathogen and can evolve to evade phage resistance, Environ Microbiol, 24, 4834, 10.1111/1462-2920.16106 · DOI
  63. Vázquez, 2021, Mining of Gram-Negative surface-active enzybiotic candidates by sequence-based calculation of physicochemical properties, Frontiers in Microbiology, 12, 10.3389/fmicb.2021.660403 · DOI
  64. Schuch, 2022, Direct lytic agents: novel, rapidly acting potential antimicrobial treatment modalities for systemic use in the era of rising antibiotic resistance, Front Microbiol, 13, 10.3389/fmicb.2022.841905 · doi:10.3389/fmicb.2022.841905
  65. Li, 2023, LysP53 activity against Salmonella and its application in decontamination of Salmonella on fresh romaine lettuce, Appl Microbiol Biotechnol, 107, 5403, 10.1007/s00253-023-12666-2 · doi:10.1007/s00253-023-12666-2
  66. Hancock, 1984, Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane, Antimicrob Agents Chemother, 26, 48, 10.1128/AAC.26.1.48 · DOI · Paper page

Cited by

See all 77

Metadata

Authors
Sisson, H. M., Jackson, S. A., Fagerlund, R. D., Warring, S. L., & Fineran, P. C.
Venue
Current Opinion in Microbiology
Publisher
Elsevier BV
Published
2024-04
Volume
78
Pages
102433
ISSN
1369-5274
Cited by
77
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gram-negative endolysins: overcoming the outer membrane obstacle. https://app.cochat.ai/papers/10.1016/j.mib.2024.102433
The paper
Sisson, H. M., Jackson, S. A., Fagerlund, R. D., Warring, S. L., & Fineran, P. C. (2024). Gram-negative endolysins: overcoming the outer membrane obstacle. Current Opinion in Microbiology. https://doi.org/10.1016/j.mib.2024.102433

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.